Navigation Links
Thoratec Reports 34 Percent Increase in 2008 Revenues
Date:2/5/2009

PLEASANTON, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today said that revenues for fiscal 2008 increased 34 percent over revenues in fiscal 2007.

For the year ended January 3, 2009, Thoratec reported revenues of $313.6 million compared with revenues of $234.8 million in fiscal 2007. Revenues for the fourth quarter of fiscal 2008 were $85.7 million, a 34 percent increase over revenues of $64.1 million in the same period a year ago.

Net income on a GAAP basis in fiscal 2008 was $22.5 million, or $0.39 per diluted share, versus GAAP net income of $3.2 million, or $0.06 per diluted share, in fiscal 2007. Non-GAAP net income, which is described later in this press release, was $36.9 million, or $0.61 per diluted share, in fiscal 2008 compared with $18.6 million, or $0.33 per diluted share, in fiscal 2007.

"This has been a truly extraordinary year for Thoratec, highlighted by the successful U.S. commercial launch of our HeartMate II(R) LVAS (Left Ventricular Assist System) for bridge-to-transplantation (BTT) and the resultant growth in revenues and earnings," noted Gary F. Burbach, president and chief executive officer.

"Our financial performance in 2008 was driven by an increase in Cardiovascular Division revenues of 49 percent year-over-year. We continue to see positive clinical results with the HeartMate II and better than expected adoption of the device by new centers. This demonstrates the effectiveness of our roll-out strategy designed to ensure that centers have the training and clinical support necessary to achieve successful patient outcomes."

The company said it added 12 new HeartMate II centers during the fourth quart
'/>"/>

SOURCE Thoratec Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Thoratec Schedules Third Quarter Conference Call, Webcast
2. Thoratecs ITC Division Receives FDA Warning Letter
3. URGENT Thoratec Corporation Worldwide Recall of Implantable Ventricular Assist Device
4. Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation
5. Thoratec Schedules First Quarter 2008 Conference Call, Webcast
6. Thoratec Schedules Second Quarter 2008 Conference Call, Webcast
7. Thoratec Reports 44 Percent Increase in Second Quarter Revenues;
8. Thoratec Presentation at Piper Jaffary Conference to be Webcast
9. Thoratec Schedules Fiscal 2008 Year-End Conference Call, Webcast
10. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
11. Haemacure Reports Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... CHAPEL HILL -- Type 2 diabetes and obesity are ... Recently published studies suggested that insulin glargine (a synthetic ... be associated with a higher risk of certain cancers ... However, these studies were unable to control for important ... association. , On the other hand, a large ...
(Date:12/14/2009)... might lead to better treatments for asthma, COPD, researchers ... have identified five genetic variants that influence lung function, ... for lung diseases. , The international team of researchers ... the 2.5 million sites across the human genome in ... the team to the five common genetic variants associated ...
(Date:12/14/2009)... report cites lower rates for meth and smoking, ... Dec. 14 (HealthDay News) -- Fewer teenagers are ... stalled and abuse of prescription drugs remains high, ... said that newer drugs, such as the hallucinogenic ... is intended for treatment of attention-deficit hyperactivity disorder ...
(Date:12/14/2009)... Today, the National Basketball Association (NBA) and the United Nations Foundation’s ... Life. See a Game. presented by HP--to send anti-malaria bed nets ... the NBA Cares Season of Giving and runs through January 31, ... ... December 14, 2009 -- Today, the National Basketball Association (NBA) and ...
(Date:12/14/2009)... to Ensure Health Workforce Recommendations are Implemented ... Congressional leaders must ensure that health reform ... sufficient authority to ensure implementation of an ... to Dr. Steven A Wartman, president and ... Centers (AAHC). "With each step in ...
Breaking Medicine News(10 mins):Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 2Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 3Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 4Health News:Health Reform Needs Enforceable National Workforce Strategy 2
... Delivers Interactive Education and Entertainment to State,s Largest Hospice ... ... S.D., Sept. 2 LodgeNet,Healthcare, a division of LodgeNet Interactive Corporation ... by bringing the,LodgeNetRX(TM) Interactive Patient Television System to the state,s first,hospice ...
... adenomas, the precursor polyps in virtually all colorectal cancers, ... increases after age 50. Additionally, African Americans have a ... have a worse prognosis for survival if the polyps ... emphasize the importance of colonoscopies, which view the entire ...
... study shows that the innate immune system of humans ... inflammation, chronic rhinosinusitis and bronchial asthma. Researchers at Mayo ... that eosinophils, a particular type of white blood cell, ... Alternaria alternata . The groundbreaking findings, which shed ...
... Insurance Professionals and Their Clients Featured in Newsweek and to be ... ... 2 Most Americans acknowledge that,insurance is important and necessary, but ... occurs like a death in the,family or a serious illness or ...
... Innovative and High Growth MedTech Companies to ... More than 50 U.S. and,international medical ... at,AdvaMed 2008: The MedTech Conference. Company presentations ... opportunity for innovators and,market leaders in the ...
... Stewart Frankel Law Firm,in New York City, recently settled a ... Fifty Thousand Dollars against the New York,City Housing Authority. The ... New York City Housing Authority, et al. alleged that the,plaintiffs ... New York,City Housing Authority., Lead is a highly toxic ...
Other Medicine News:Health News:LodgeNet Healthcare Expands Into Hawaii Through Agreement With St. Francis Hospice 2Health News:LodgeNet Healthcare Expands Into Hawaii Through Agreement With St. Francis Hospice 3Health News:Study confirms colorectal cancer screening should start at age 50 2Health News:Innate immune system targets asthma-linked fungus for destruction 2Health News:Innate immune system targets asthma-linked fungus for destruction 3Health News:LIFE Foundation Announces 2008 realLIFEstories Award Recipients to Illustrate Benefits of Life and Disability Insurance 2Health News:LIFE Foundation Announces 2008 realLIFEstories Award Recipients to Illustrate Benefits of Life and Disability Insurance 3Health News:LIFE Foundation Announces 2008 realLIFEstories Award Recipients to Illustrate Benefits of Life and Disability Insurance 4Health News:Canadian, German, Israeli, New Zealand, U.K and U.S. Companies Selected to Make Company Presentations at AdvaMed 2008 2Health News:Canadian, German, Israeli, New Zealand, U.K and U.S. Companies Selected to Make Company Presentations at AdvaMed 2008 3Health News:Canadian, German, Israeli, New Zealand, U.K and U.S. Companies Selected to Make Company Presentations at AdvaMed 2008 4Health News:Lead Poisoned Family Reaches Two Million and Fifty Thousand Dollar Settlement of Lawsuit 2
(Date:12/14/2009)... Conn., Dec. 14 Zargis Medical Corp., ... SPDE ) and a spin-off from Siemens Corporate ... that it has begun selling its award-winning Zargis ... ,, Cardioscan and its accompanying Bluetooth®-enabled electronic stethoscope ... "2009 Innovation of the Year." ...
(Date:12/14/2009)... Southridge LLC ("Southridge"), an investment firm that ... to announce that its affiliated fund has closed a ... in equity financing to Imaging Diagnostic Systems, Inc. (OTCBB: ... the growth of Imaging Diagnostic Systems, Southridge has paved ... in the field of early breast cancer detection," said ...
(Date:12/14/2009)... 14 Cardium Therapeutics (NYSE Amex: ... Study of GAM501 (Ad5PDGF-B/Collagen) in the Treatment of ... Science and Industry Conference held December 10-13, 2009 ... conference is attended by top industry leaders and ... healing. Dr. Barbara K. Sosnowski, Cardium,s Vice ...
Breaking Medicine Technology:Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com 2Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc. 2Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 2Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 3Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 4Lockton Outlines Implications of Proposed Health Reform Plans 62453 1Lockton Outlines Implications of Proposed Health Reform Plans 62453 2Oncolytics Biotech 28R 29 Inc Announces Exercise of Underwriters Over Allotment Option 15047 1Oncolytics Biotech 28R 29 Inc Announces Exercise of Underwriters Over Allotment Option 15047 2Oncolytics Biotech 28R 29 Inc Announces Exercise of Underwriters Over Allotment Option 15047 3Oncolytics Biotech 28R 29 Inc Announces Exercise of Underwriters Over Allotment Option 15047 4Deadline Approaching for Largest Commercialization Event for Nanotech 26amp 3B Clean Technologies 15044 1Deadline Approaching for Largest Commercialization Event for Nanotech 26amp 3B Clean Technologies 15044 2Deadline Approaching for Largest Commercialization Event for Nanotech 26amp 3B Clean Technologies 15044 3
... SPEX ) reported that patient recruitment for its Phase ... Naturlose(R), has begun in,India. Expectations for India are to ... the pivotal Phase 3 trial. "Now that enrollment efforts,are ... trial will be completed,on schedule as reported during the ...
... 6 Cadence Pharmaceuticals,Inc. (Nasdaq: CADX ), ... proprietary product candidates principally,for use in the hospital ... and nine months ended September 30, 2008., ... clinical development,programs for its two Phase III product ...
Other Medicine Technology:Patient Recruitment Begins in India for Phase 3 Diabetes Trial 2Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 2Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 3Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 4Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 5Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 6Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 7Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 8